ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 58 filers reported holding ALX ONCOLOGY HLDGS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $509,000 | – | 13,489 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $92,828,000 | 21.48% |
| Vivo Capital, LLC | 4,220,048 | $40,386,000 | 4.46% |
| Logos Global Management LP | 2,971,352 | $28,436,000 | 3.50% |
| Samsara BioCapital, LLC | 262,786 | $2,515,000 | 0.59% |
| Orbimed Advisors | 2,871,000 | $27,475,000 | 0.51% |
| Cormorant Asset Management, LP | 712,079 | $6,815,000 | 0.48% |
| Pier Capital, LLC | 272,617 | $2,609,000 | 0.45% |
| Redmile Group, LLC | 752,097 | $7,198,000 | 0.28% |
| Nan Fung Group Holdings Ltd | 41,950 | $401,000 | 0.26% |
| Artal Group S.A. | 500,000 | $4,785,000 | 0.20% |